Businesses in the Bailiwick of Guernsey can now apply for high-THC medical cannabis cultivation licences for use in cannabis-based medicinal products (CBMP) under its revised licensing regime.
In a significant step in the development of the emerging cannabis industry in Guernsey, businesses in the Bailiwick can now apply for a high-THC cannabis cultivation licence following a Memorandum of Understanding (MoU) with the UK Home Office. Previously only licences to cultivate cannabis for CBD products were available.
Revised licensing regime
Applications will be received by the newly formed Bailiwick of Guernsey Cannabis Agency (BGCA), which has been established by the Committee for Health and Social Care.
“Guernsey was one of the first to recognise the potential benefits that cannabis-based products medicinal might bring,” commented Deputy Al Brouard, president of the Committee for Health and Social Care.
“The MoU marks the start of a process that may allow these products to be produced on island for the benefit of patients within the Bailiwick and overseas. The creation of the Bailiwick of Guernsey Cannabis Agency further enhances our robust regulatory system for cannabis cultivation.”
Deputy Neil Inder, President of the Committee for Economic Development added: “Guernsey’s famous growing heritage continues to thrive within this new island industry. The MoU ensures that the Bailiwick can continue to remain at the forefront of a developing sector that provides diversification to our economy, revitalisation of our environment and new opportunities for skills and employment.
“Growers once moved into finance and now finance is moving into growing. The Committee will continue to support the opportunities available in the pharmaceutical industry and I’m very grateful for the effort all parties have made to deliver the long-awaited MoU.”
[activecampaign form=31]
